Item 2.01 Completion of Acquisition or Disposition of Assets
On
The closing of the Asset Sale was effected on
As consideration for the Asset Sale, Hill Street has issued CanPharm the
following: (i)
© Edgar Online, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.34 USD | +1.30% | -12.03% | +87.20% |
Apr. 16 | Lexaria Obtains Ethics Review Board Approval to Start New GLP-1 Study | MT |
Apr. 16 | Lexaria Bioscience Corp. Receives Ethics Review Board Approval to Begin New GLP-1 Study | CI |
Item 2.01 Completion of Acquisition or Disposition of Assets
On
The closing of the Asset Sale was effected on
As consideration for the Asset Sale, Hill Street has issued CanPharm the
following: (i)
© Edgar Online, source
1st Jan change | Capi. | |
---|---|---|
+87.20% | 30.15M | |
+28.79% | 676B | |
+24.81% | 554B | |
-7.64% | 349B | |
+15.00% | 318B | |
+5.99% | 291B | |
+2.47% | 210B | |
-0.02% | 204B | |
-9.98% | 194B | |
-11.71% | 144B |